Literature DB >> 11901074

Serum CrossLaps: pediatric reference intervals from birth to 19 years of age.

Patricia M Crofton, Nancy Evans, Mervyn R H Taylor, Celia V Holland.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11901074

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  11 in total

1.  Short-term bone biochemical response to a single bout of high-impact exercise.

Authors:  Timo Rantalainen; Ari Heinonen; Vesa Linnamo; Paavo V Komi; Timo E S Takala; Heikki Kainulainen
Journal:  J Sports Sci Med       Date:  2009-12-01       Impact factor: 2.988

2.  Reference values of bone stiffness index and C-terminal telopeptide in healthy European children.

Authors:  D Herrmann; T Intemann; F Lauria; S Mårild; D Molnár; L A Moreno; I Sioen; M Tornaritis; T Veidebaum; I Pigeot; W Ahrens
Journal:  Int J Obes (Lond)       Date:  2014-09       Impact factor: 5.095

3.  Effect of haemodialysis on markers of bone turnover in children.

Authors:  Simon Waller; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

4.  The novel bone alkaline phosphatase B1x isoform in children with kidney disease.

Authors:  Diana Swolin-Eide; Sverker Hansson; Lasse Larsson; Per Magnusson
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

5.  Predicting bone mineral acquisition during puberty: data from a 3-year follow-up study in Hamamatsu, Japan.

Authors:  Katsuyasu Kouda; Kumiko Ohara; Harunobu Nakamura; Yuki Fujita; Masayuki Iki
Journal:  J Bone Miner Metab       Date:  2016-03-11       Impact factor: 2.626

6.  Dietary protein intake and bone mineral content in adolescents-The Copenhagen Cohort Study.

Authors:  A Z Budek; C Hoppe; H Ingstrup; K F Michaelsen; S Bügel; C Mølgaard
Journal:  Osteoporos Int       Date:  2007-07-17       Impact factor: 4.507

7.  Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment.

Authors:  Bernadette Anna Sophia Jaeger; Josephine Tabea Tauer; Anna Ulmer; Eberhard Kuhlisch; Heinz Juergen Roth; Meinolf Suttorp
Journal:  Med Sci Monit       Date:  2012-12

8.  Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.

Authors:  Harjit P Bhattoa; Etienne Cavalier; Richard Eastell; Annemieke C Heijboer; Niklas R Jørgensen; Konstantinos Makris; Candice Z Ulmer; John A Kanis; Cyrus Cooper; Stuart L Silverman; Samuel D Vasikaran
Journal:  Clin Chim Acta       Date:  2020-12-28       Impact factor: 6.314

9.  Therapy with pamidronate in children with osteogenesis imperfecta.

Authors:  Otilia Marginean; Raluca Corina Tamasanu; Niculina Mang; Ioana Mozos; Giorgiana Flavia Brad
Journal:  Drug Des Devel Ther       Date:  2017-08-28       Impact factor: 4.162

10.  The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial.

Authors:  Madeleine Rooney; Nick Bishop; Joyce Davidson; Michael W Beresford; Clarissa Pilkington; Janet Mc Donagh; Sue Wyatt; Janet Gardner-Medwin; Rangaraj Satyapal; Jacqui Clinch; Helen Foster; Mark Elliott; Rejina Verghis
Journal:  EClinicalMedicine       Date:  2019-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.